Showing results (881-890 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|April 26, 2019
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung CancerFiamma Berner, David Bomze, Stefan Diem, et al.
JAMA Oncology|October 17, 2018
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung CancerCharu Aggarwal, Jeffrey C Thompson, Taylor A Black, et al.
JAMA Oncology|October 17, 2018
Humanized 3F8 Anti-GD2 Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma: A Phase 1 Clinical TrialBrian H Kushner, Irene Y Cheung, Shakeel Modak, et al.
JAMA Oncology|May 3, 2019
Analysis of Control Arm Quality in Randomized Clinical Trials Leading to Anticancer Drug Approval by the US Food and Drug AdministrationTalal Hilal, Mohamad Bassam Sonbol, Vinay Prasad
JAMA Oncology|July 21, 2018
Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialAaron J Grossberg, Xiudong Lei, Ting Xu, et al.
JAMA Oncology|October 21, 2021
Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer ScreeningIakovos Toumazis, Koen de Nijs, Pianpian Cao, et al.
JAMA Oncology|October 14, 2021
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates: A ReviewPaolo Tarantino, Shanu Modi, Sara M Tolaney, et al.
JAMA Oncology|September 23, 2021
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate CancerRahul Aggarwal, Nicholas R Rydzewski, Li Zhang, et al.
JAMA Oncology|October 28, 2021
Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors: A Systematic ReviewEmily R Nadelmann, Jennifer E Yeh, Steven T Chen
JAMA Oncology|May 5, 2022
Racial and Ethnic Differences in Hysterectomy-Corrected Uterine Corpus Cancer Mortality by Stage and Histologic SubtypeMegan A Clarke, Susan S Devesa, Anne Hammer, et al.
Pageof 161